LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Organizer
Evosep Biosystems
Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster. We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.
Tags
Sample prep
LC/MS
LC/MS/MS
LC/Orbitrap
LC/HRMS
LC/QQQ
Logo of LinkedIn

Targeted Workflows

RECORD | Already taken place Th, 27.4.2023
Targeted workflows are particularly interesting for identifying established biomarkers in various applications.
Go to the webinar
Evosep: Targeted Workflows

Evosep: Targeted Workflows

Targeted workflows are particularly interesting for identifying established biomarkers in various applications. The focus on these workflows, coupled with technological advancements, is continually expanding the boundaries of high-throughput targeted analysis.

Next Generation of absolute protein Quantitation in Biological Matrixes; higher multiplexicity while faster, robust and sensitive

  • Presenter: Dr. Christoph Borchers (Mcgill university)

The accurate and rapid determination of protein concentrations using multiplexed multiple reaction monitoring (MRM) with isotope-labeled internal standards has the potential to revolutionize biochemistry and medical sciences. The combination of an Evosep One LC with an Agilent QQQ6495C allows a several-fold reduction of analysis time while maintaining high multiplexicity. As an example, we show the use of a multi-protein method for the absolute quantitation of 270 proteins, combined with metabolomics and Artificial Intelligence (AI), to analyze the plasma of a COVID cohort for prediction of survival. Moreover, optimization of the Evosep/6495C combination allowed adaptation of the 270-protein MRM method to a 24-minute gradient, thus doubling the throughput compared to before.

Development of a LC-MS/MS Method for Measurement of Fusion Sarcoma Proteins in Plasma

  • Presenter: Phd. AnThony Maus (Clinical Mass Spec. Development Laboratory, Mayo Clinic)

Sarcoma is general term for a group of over 70 cancers that are classified using genomic techniques to identify characteristic gene fusions in tumor tissues. However, this technique requires relatively invasive biopsies and is not conducive to monitoring disease progression or response to treatment. Measurements of fusion protein biomarkers in plasma would overcome these limitations. We sought to develop an LC-MS/MS method capable of performing these measurements by conducting discovery experiments on cell lines with an EvoSep coupled to an Exploris 480 mass spectrometer. Using these data, we developed a targeted method and performed measurements in plasma samples.

Evosep Biosystems
 

Related content

Deeper proteome coverage and faster throughput for single-cell samples on the Orbitrap Astral mass spectrometer

Technical notes
| 2024 | Thermo Fisher Scientific
Instrumentation
LC/Orbitrap, LC/HRMS, LC/MS/MS, LC/MS
Manufacturer
Thermo Fisher Scientific
Industries
Proteomics

Purity quantification of tris(hydroxymethyl)aminomethane (TRIS) with IC

Applications
| 2024 | Metrohm
Instrumentation
Ion chromatography
Manufacturer
Metrohm
Industries
Pharma & Biopharma, Clinical Research

Quantitation of N-Nitroso-Propranolol in Drug Substance using LC-MS/MS

Applications
| 2024 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Waters
Industries
Pharma & Biopharma

Analysis of PFAS by EPA Methods 533, 537.1, and 8327

Guides
| 2024 | Agilent Technologies
Instrumentation
Standards
Manufacturer
Agilent Technologies
Industries
Environmental

DMT-on Purification of Phosphorothioate Oligonucleotide Using SHIMSEN Styra HLB SPE Cartridge

Applications
| 2024 | Shimadzu
Instrumentation
Sample Preparation, Consumables, HPLC
Manufacturer
Shimadzu
Industries
Proteomics
Other projects
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike